NCT02928718View on ClinicalTrials.gov

The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

September 29, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

July 31, 2019

Conditions
Acute Pancreatitis
Interventions
PROCEDURE

ERCP

Two expert endoscopists will perform ERCP. Patients will be sedated with midazolam(2-5mg) and pethidine(25-50mg) with careful monitoring. Duodenoscope (TJF-240 or TJF-260; Olympus Corp., Tokyo, Japan) will be used. Cholangiography or pancreatography will be gathered after selective bile duct or pancreatic duct cannulation. Therapy such as endoscopic sphincterotomy, stent insertion, and etc., will be done.

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02928718 - The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations | Biotech Hunter | Biotech Hunter